Solasia Pharma K.K. (FRA:9SO)
0.1360
-0.0010 (-0.73%)
At close: Jan 22, 2026
Solasia Pharma K.K. Revenue
Solasia Pharma K.K. had revenue of 42.00M JPY in the quarter ending September 30, 2025, with 366.67% growth. This brings the company's revenue in the last twelve months to 326.00M, up 239.58% year-over-year. In the year 2024, Solasia Pharma K.K. had annual revenue of 316.00M, down -48.78%.
Revenue (ttm)
326.00M JPY
Revenue Growth
+239.58%
P/S Ratio
21.42
Revenue / Employee
14.17M JPY
Employees
23
Market Cap
40.21M EUR
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 316.00M | -301.00M | -48.78% |
| Dec 31, 2023 | 617.00M | -475.00M | -43.50% |
| Dec 31, 2022 | 1.09B | 533.00M | 95.35% |
| Dec 31, 2021 | 559.00M | 105.00M | 23.13% |
| Dec 31, 2020 | 454.00M | -856.00M | -65.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 1.22B |
| PEH Wertpapier AG | 183.79M |
| edding AG | 149.67M |
| Fernheizwerk Neukölln Aktiengesellschaft | 66.35M |
| SBF AG | 46.20M |
| Alexanderwerk Aktiengesellschaft | 33.44M |
| Fair Value REIT-AG | 28.37M |
| Enapter AG | 22.54M |